Max Robotics — Global Service Robot Directory + US Certification

About

Michael Hornsby is a leading figure in the development of high-throughput technologies for generating recombinant antibodies, a field critical to both basic biological research and clinical applications. His work directly addresses the limitations of traditional monoclonal antibody production, which often fails to provide renewable, standardized reagents. Hornsby’s major contributions center on industrialized, scalable platforms for antibody discovery and validation. His most-cited work, “A High Through-put Platform for Recombinant Antibodies to Folded Proteins” (120 citations), describes a groundbreaking system for producing validated recombinant antibodies against 346 transcription factors, demonstrating a powerful, permanent resource for the research community. Complementing this, his work on “Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries” (33 citations) outlines an alternative, high-efficiency method to meet the growing global demand for high-quality antibodies. By engineering robust, automated pipelines for antigen production and antibody selection, Hornsby has provided the scientific community with essential tools that ensure reproducibility and long-term access to critical reagents, marking a significant advance in the industrialization of antibody engineering.